Results 161 to 170 of about 9,354,751 (270)

Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis

, 2017
OBJECTIVES: We reclassified Korean patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) into 3 categories of AAV including MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis, and investigated clinical and prognostic features.
유주영, 안성수, 송정식, 이상원, 박용범, 정승민   +5 more
core  

Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis

, 2003
Antineutrophil cytoplasm autoantibody (ANCA)-associated small vessel vasculitides are systemic diseases. characterized by chronic inflammation of blood vessels.
Limburg, PC, van Rossum, AP, Kallenberg, CGM   +2 more
core   +1 more source

Forest plot of association between ANCA-associated vasculitis (AASV) and overall cancer.

, 2015
Forest plot of association between ANCA-associated vasculitis (AASV) and overall cancer.
Yong Ning (726887), Gang Xu (219455), Shuiming Guo (739345), Rui Zeng (468447), Weifeng Shang (739343), Menglan Li (739344), Shuwang Ge (470987), Xiu Xu (498635), Min Han (56772)   +8 more
core   +1 more source

Evaluation of ANCA testing by antigen-specific assays in small vessel vasculitis patients

Egyptian Rheumatology and Rehabilitation
Introduction Antineutrophil cytoplasmic antibodies (ANCA) testing is a screening method that may be applied in clinical practice. Testing for vasculitis linked to antineutrophil cytoplasmic antibodies (AAV) usually involves these measurements.
Mai Mahmoud Fahmy Mansour, Laila Mohamed Yousef, Essam Mohammed Abu alFadl, Hiroaki Dobashi, Rabab Hussein Ali Ahmed, Osama Sayed Daifallah Mohamed   +5 more
doaj   +1 more source

ANCA-associated vasculitis in children

Nephrology Dialysis Transplantation, 2022
Silvia, Bernardi, Laure, Seugé, Olivia, Boyer   +2 more
openaire   +2 more sources

Pharmacogenetics of rituximab in anca-associated vasculitis

, 2017
Background: Rituximab is effective for induction and maintenance of remission in ANCA-associated vasculitis; however, response to treatment is highly variable and relapse is common after its discontinuation. Biomarkers predicting response to rituximab do
Alberici, Federico
core  

Avacopan in the treatment of ANCA-associated vasculitis

Expert Opinion on Investigational Drugs, 2018
V. Tesar, Z. Hruskova
semanticscholar   +1 more source

IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis

, 2019
Low levels of IgM auto-antibodies have been reported in health and disease. IgM anti-neutrophil cytoplasmic antibodies (ANCA) have been reported in patients with ANCA-associated vasculitis (AAV).
Davey, E (15697319), Jeffs, LS (15606410), Tan, PG (15697316), Hurtado, PR (15606416), Peh, CA (15606413), Nelson, A (15557789), Perkins, GB (15697322), Katherine Chappell (14733487)   +7 more
core  

Exploration of the genetic architecture of ANCA-associated vasculitis. [PDF]

EBioMedicine
Byun J, Shaw VR, Zhu C, Han Y, Sun R, Zhang Z, Xiao X, Pinder BD, Zhang J, Tadesse Y, Riley TR, Chung S, Cuthbertson D, Dellaripa PF, Dua AB, Gewurz-Singer O, Forbess LJ, Langford CA, Khalidi N, Koening C, Mahr AD, McAlear C, Monach PA, Moreland L, Pagnoux C, Seo EP, Specks U, Spiera RF, Sreih A, Springer JM, St Clair EW, Warrington KJ, Ytterberg SR, Edberg JC, Grayson PC, Jayne D, Smith R, Walsh M, Merkel PA, Siminovitch KA, Amos CI, Vasculitis Clinical Research Consortium.   +41 more
europepmc   +1 more source

Vessels and Valves: Cardiac Manifestations of ANCA-Associated Vasculitis

Vessels and Valves: Cardiac Manifestations of ANCA-Associated Vasculitis. Dr. Asim Khanfar, R2, Internal Medicine Resident Program, Rochester General Hospital; Dr. Anthony Ocon, MD PhD, Rheumatology, Rochester Regional Health Objectives: Present unique
Ocon, Anthony, Khanfar, Asim
core